Abstract
The principle of therapeutic nucleic acid repair has been demonstrated in cell-free and cell culture experiments, in which compounds bind to and repair mutated sequences, thereby treating the primary defects of genetic disease. The mechanisms used to promote repair are diverse, encompassing techniques related to antisense, triple-strand, and ribozymes. Therapeutic nucleic acid repair has the potential to revert mutations to wild type, and therefore is more suitable than traditional gene therapy for treating gain-of-function mutations.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Woolf, T.W., Chase, J.M., and Stinchcomb, D. 1995. Towards the therapeutic editing of mutated RNA sequences. Proc. Natl. Acad. Sci. USA 92: 8298–8302.
Sierakowska, H., Sambade, M.J., Agrawal, S., and Kole, R. 1996. Repair or thalassemic human beta-globin mRNA in mammalian cells by antisense oligonucleotides. Proc. Natl, Acad. Sci. USA 93: 12840–12844.
Cole-Strauss, A., Yoon, K., Xiang, Y., Byrne, B.C., Rice, M.C., Kollman, W.K., and Kmiec, E.B. 1996. Correction of the mutation responsible for sickle cell anemia by an RNA-DNA Oligonucleotide. Science 273: 1386–1389.
Jones, J.T., Seong-Wook, L., and Sullenger, B.A. 1996. Tagging ribozyme reaction sites to follow trans-splicing in mammalian cells. Nat. Med. 2: 643–648.
Verma, I.M. and Somia, N. 1998. Gene therapy- promises, problems and prospects. Nature 389: 239–242.
Vlassov, V., Gaidamakov, S., Zarytova, V., Knorre, D., Levina, A., Nikonova, A. et al. 1988. Sequence-specific chemical modification of double-stranded DNA with alkylating oligodeoxyribonucleotide derivatives. Gene 72: 313–322.
Giovannangeli, C., Thuong, N., and Helene, C. 1992. Oligodeoxynucleotide-directed photo-induced cross-linking of HIV proviral DNA via triple-helix formation. Nucl. Acids Res. 20: 4275–4281.
Wang, G., Levy, D., Seidman, M., and Glazer, P. 1995. Targeted mutagenesis in mammalian cells mediated by intracellular triple helix formation. Mol. Cell Biol. 15: 1759–1568.
Vickers, T.A., Griffith, M.C., Ramasamy, K., Risen, L.M., and Freier, S.M. 1995. Inhibition of NF-kappa B specific transcriptional activation by PNA strand invasion. Nucl. Acids Res. 23: 3003–3008.
Maher, L.d. and Dolnick, B.J. 1988. Comparative hybrid arrest by tandem anti-sense oligodeoxyribonucleotides or oligodeoxyribonucleoside methylphosphonates in a cell-free system. Nucl. Acids Res. 16: 3341–3358.
Melton, D.A. 1985. Injected antisense RNAs specifically block messenger RNA translation in vivo. Proc. Natl. Acad. Sci. USA 82: 144–148.
Lewin, B. 1990. Genes. Cell Press, Cambridge, UK.
Lukhtanoz, E.A., Mills, A.G., Kutyavin, I.V, Gorn, V.V., Reed, M.W. and Meyer, R.B. 1997. Minor groove DNA alkylation directed by major groove triplex-forming oligodeoxyribonucleotides. Nucl. Acids. Res. 25: 5088–5084.
Bartel, D.P. and Szostak, J.W. 1993. Isolation of new ribozymes from a large pool of random sequences. Science 261: 1411–1418.
Kren, B., Cole-Strauss, A., Kmiec, E., and Steer, C. 1997. Targeted nucleotide exchange in the alkaline phosphatase gene of HuH-7 cells mediated by a chimeric RNA/DNA Oligonucleotide. Hepatology 25: 1462–1468.
Yoon, K., Cole-Strauss, A., and Kmiec, E.B. 1996. Targeted gene correction of episomal DNA in mammalian cells mediated by a chimeric RNA:DNA Oligonucleotide. Proc. Natl. Acad. Sci. USA 93: 2071–2075.
Kren, B.T., Bandyopadhyay, P., and Steer, C.J. 1998. In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides. Nat. Med. 4: 285–290.
Dominski, Z. and Kole, R. 1993. Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides. Proc. Natl. Acad. Sci. USA 90: 8673–8677.
Sullenger, B. and Cech, T.R. 1994. Ribozyme-mediated repair of defective mRNA by targeted trans-splicing. Nature 371: 619–622.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Woolf, T. Therapeutic repair of mutated nucleic acid sequences. Nat Biotechnol 16, 341–344 (1998). https://doi.org/10.1038/nbt0498-341
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt0498-341
This article is cited by
-
To cleave or not to cleave: therapeutic gene editing with and without programmable nucleases
Nature Reviews Drug Discovery (2017)
-
Engineering and optimising deaminase fusions for genome editing
Nature Communications (2016)
-
Photouncaged Sequence-specific Interstrand DNA Cross-Linking with Photolabile 4-oxo-enal-modified Oligonucleotides
Scientific Reports (2015)
-
In vitrocorrection of cystic fibrosis epithelial cell lines by small fragment homologous replacement (SFHR) technique
BMC Medical Genetics (2002)
-
RNA repair as a novel to genetic therapy
Gene Therapy (1999)
